Introduction:Pazopanib is an oral protein kinase inhibitor(PKI)that targets vascular endothelial growth factor(VEGF)receptors,fibroblastic growth factor recepto
Delivering therapeutics to the central nervous system(CNS) and brain-tumor has been a major challenge. The current standard treatment approaches for the brain-t